Evidence map›Paper›PMID 31873936›Full record

ArticleHead and neck pathology2020

A Comparative Analysis of p63 Expression in Giant Cell Tumour (GCT), Central Giant Cell Granuloma (CGCG) and Peripheral Giant Cell Granuloma (PGCG).

Saurabh R Nagar, Shivani Bansal, Kusum Jashnani, Anuradha Sinha, Rajiv S Desai

Open access · greenAbstract readComparative Study
In one paragraph

Article in Head and neck pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Giant Cell Tumor of the Mandible: A Case Report with an Argument on a Possible Diagnostic Tool.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  8. Article
  9. Article
  10. Peripheral giant cell granuloma - Case report.Journal of dental sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Saurabh R NagarDepartment of Oral Pathology & Microbiology, Government Dental College & Hospital, PD'Mello Road, St. George Hospital Campus, Near Chatrapati Shivaji Terminus, Mumbai, Maharashtra, 400001, India.
Shivani BansalDepartment of Oral & Maxillofacial Pathology, Nair Hospital Dental College, Dr. A.L. Nair Road, Mumbai Central, Mumbai, 400008, India. bshivani2000@gmail.com.ORCID http://orcid.org/0000-0003-1163-5418
Kusum JashnaniDepartment of Pathology, BYL Nair Ch. Hospital & T.N.M.C., Mumbai Central, Mumbai, 400008, India.
Anuradha SinhaDepartment of Oral Pathology & Microbiology, Government Dental College & Hospital, PD'Mello Road, St. George Hospital Campus, Near Chatrapati Shivaji Terminus, Mumbai, Maharashtra, 400001, India.
Rajiv S DesaiDepartment of Oral & Maxillofacial Pathology, Nair Hospital Dental College, Dr. A.L. Nair Road, Mumbai Central, Mumbai, 400008, India.
Government Dental College and Hospital · INTopiwala National Medical College & BYL Nair Charitable Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell tumour (GCT) is locally aggressive benign neoplasm of long bones whereas giant cell granulomas; central giant cell granuloma (CGCG) and peripheral giant cell granuloma (PGCG); are tumour-like conditions of the oral cavity. This study aimed to evaluate and compare the immunohistochemical expression of p63 in GCT, CGCG, PGCG and determine whether p63 can be used as a diagnostic, prognostic and differential biomarker between these entities. Histopathologically diagnosed 10 cases of GCT, 20 cases of CGCG and 20 cases of PGCG were subjected to p63 immunohistochemical staining. The percentage of p63-positive cells was semi-quantitatively assessed on the whole section. Intergroup comparison was done using Kruskal-Wallis test and one-way ANOVA. The value p < 0.05 was considered to be statistically significant and value p < 0.01 was considered to be statistically highly significant. p63 immunoexpression was seen in 100% (10/10) cases of GCT whereas CGCG and PGCG revealed the complete absence of p63 immunopositivity. These results showed a highly significant difference in p63 expression between GCT, CGCG and PGCG (p < 0.01). No difference was noted between CGCG and PGCG. GCT is a distinct entity when compared with CGCG and PGCG. Even aggressive CGCG also did not show p63 immunopositivity, so it is not a prognostic marker. Also, p63 cannot differentiate between CGCG and PGCG.

Indexed as

AdultBiomarkers, TumorChildFemaleGiant Cell Tumor of BoneGranuloma, Giant CellHumansJaw DiseasesMaleMembrane ProteinsYoung AdultBiomarkers, TumorCKAP4 protein, humanMembrane ProteinsGiant cell granulomasGiant cell tumourImmunohistochemistryp63

Identifiers

PMID31873936
PMCPMC7413967
OpenAlexW2998408714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.